Business, energy, technology, markets and global industry news from Business News Today

Clearmind Medicine Inc.

Pharma & Biotech

How Clearmind Medicine is positioning CMND-100 within the emerging non-hallucinogenic neuroplastogen market

Clearmind Medicine is advancing CMND-100 in Alcohol Use Disorder. Discover why the non-hallucinogenic neuroplastogen market is gaining attention.

Read More
Pharma & Biotech

Clearmind Medicine Inc. and Polyrizon Ltd. target formulation risk in MEAI’s addiction program

Discover how Clearmind Medicine Inc.’s intranasal MEAI strategy could reshape CNS drug delivery and clinical outcomes. Read the analysis.

Read More